Seyfarth Shaw has been selected as a finalist in the M&A Advisor Awards 2017 “Healthcare and Life Sciences Deal of the Year (Under $100MM)” category for its representation of Morholdings, Inc. in the Morrisey/HealthStream deal. In its 16th year, the M&A Advisor Awards recognize the leading dealmakers, firms and transactions of the year while celebrating the creativity, perseverance and ingenuity of the M&A industry’s professionals.
Seyfarth has been selected from the nominees in the first stage of evaluation, and the ultimate award winners will be announced at the Awards gala on November 13th at the Metropolitan Club in New York. The M&A Advisor was founded in 1998 to offer insights and intelligence on mergers and acquisitions through the industry’s leading publication. To learn more, visit here.